CompletedPhase 4NCT04639674
AST-120 in Hemodialysis Patients With Uremic Pruritus
Studying Uremic pruritus
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Conmed Pharmaceutical & Bio-Medical Corporation
- Principal Investigator
- Po-Sung Lin, Dr.Tungs' Taichung MeltroHarbor Hospital
- Intervention
- AST-120(drug)
- Enrollment
- 100 target
- Eligibility
- All sexes
- Timeline
- 2020 – 2022
Study locations (7)
- Kaohsiung Medical University Hospital, Kaohsiung City, Taiwan
- Taipei Tzu Chi Hospital, New Taipei City, Taiwan
- Fu Jen Catholic University Hospital, New Taipei City, Taiwan
- Taichung Veterans General Hospital, Taichung, Taiwan
- Tungs' Taichung MetroHarbor Hospital, Taichung, Taiwan
- Tri-Service General Hospital, Taipei, Taiwan
- Chang-Gung Memorial Hospital, Taoyuan District, Taiwan
Collaborators
Tri-Service General Hospital · Tungs' Taichung Metroharbour Hospital · Chang Gung Memorial Hospital · Taichung Veterans General Hospital · Kaohsiung Medical University · Taichung Tzu Chi Hospital · Fu Jen Catholic University
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04639674 on ClinicalTrials.govOther trials for Uremic pruritus
Additional recruiting or active studies for the same condition.